Cargando…
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Triple-Negative Breast Cancer (TNBC) has a poor prognosis and adverse clinical outcomes among all breast cancer subtypes as there is no available targeted therapy. Overexpression of Enhancer of zeste homolog 2 (EZH2) has been shown to correlate with TNBC’s poor prognosis, but the contribution of EZH...
Autores principales: | Verma, Ayushi, Singh, Akhilesh, Singh, Manish Pratap, Nengroo, Mushtaq Ahmad, Saini, Krishan Kumar, Satrusal, Saumya Ranjan, Khan, Muqtada Ali, Chaturvedi, Priyank, Sinha, Abhipsa, Meena, Sanjeev, Singh, Anup Kumar, Datta, Dipak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708848/ https://www.ncbi.nlm.nih.gov/pubmed/36446780 http://dx.doi.org/10.1038/s41467-022-35059-x |
Ejemplares similares
-
Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer
por: Saini, Krishan Kumar, et al.
Publicado: (2023) -
CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5
por: Nengroo, Mushtaq A., et al.
Publicado: (2021) -
Inhibition of p21 activates Akt kinase to trigger ROS-induced autophagy and impacts on tumor growth rate
por: Maheshwari, Mayank, et al.
Publicado: (2022) -
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023) -
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Singh, Desh Deepak, et al.
Publicado: (2021)